References
- Matsumura I, Mizuki M, Kanakura Y. Roles for deregulated receptor tyrosine kinases and their downstream signaling molecules in hematologic malignancies. Cancer Sci 2008;99:479–485.
- Wong S, Witte ON. The BCR-ABL story: bench to bedside and back. Annu Rev Immunol 2004;22:247–306.
- Fedele R, Martino M, Cuzzola M, et al. Imatibib mesylate in T-cell large granular lymphocyte leukemia associated with chronic graft-versus-host disease. Leuk Lymphoma 2011;52:XXX–XXX.
- Yang J, Liu X, Nyland S, et al. Platelet-derived growth factor mediates survival of leukemic large granular lymphocytes via an autocrine regulatory pathway. Blood 2010;115:51–60.
- Lamy T, Bauer FA, Liu JH, Li YX, Loughran TP. Clinicopathological features of aggressive large granular lymphocyte leukaemia resemble Fas ligand transgenic mice. Br J Haematol 2000:108:717–723.
- Gaine P, Rubin PJ. Primary pulmonary hypertension. Lancet 1998;352:719–725.
- Tajsic T, Morrell NW. Cellular and molecular mechanisms of pulmonary vascular smooth muscle cell proliferationIn: Yuan JX-J, Garcia JGN, West JB, Hales CA, Rich S, Archer SL, editors. Textbook of pulmonary vascular disease. New York: Springer; 2011. pp 323–334.
- Rossoff LJ, Genovese J, Coleman M, Dantzker DR. Primary pulmonary hypertension in a patient with CD8/T-cell large granulocyte leukemia: amelioration by cladribine therapy. Chest 1997;112:551–553.
- Chen XH, Bai F, Sokol L, Zhou JM, Ren A, Painter JS. A critical role for DAP10 and DAP12 in CD8+ T cell-mediated tissue damage in large granular lymphocyte leukemia. Blood 2009;113:3226–3234.
- Svegliati S, Olivieri S, Campelli N, Luchetti M, Poloni A, Trappolini S. Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease. Blood 2007;110:237–241.